Confluence Life Sciences, Inc.
Records under this name other than patents Confluence Life Sciences, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Confluence Life Sciences, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,056,110 | Substituted Pyrimidinone-Phenyl-Pyrimidinyl Compounds now held by Aclaris Therapeutics, Inc. In force · High confidence | In force | High confidence | |
| US 9,115,089 | Methyl/Fluoro-Pyridinyl-Methoxy Substituted Pyridinone-Pyridinyl Compounds and Fluoro-Pyrimidinyl-Methoxy Substituted Pyridinone-Pyridinyl Compounds now held by Aclaris Therapeutics, Inc. In force · High confidence | In force | High confidence | |
| US 9,145,393 | Arylpyridinone Itk Inhibitors for Treating Inflammation and Cancer now held by Aclaris Therapeutics, Inc. In force · High confidence | In force | High confidence | |
| US 10,150,783 | Heterocyclic Itk Inhibitors for Treating Inflammation and Cancer now held by Aclaris Therapeutics, Inc. In force · High confidence | In force | High confidence | |
| US 8,563,558 | Substituted Pyridine Urea Compounds now held by Aclaris Therapeutics, Inc. Lapsed on the fee record Ended Oct 22, 2025 · High confidence | Lapsed on the fee record | Ended Oct 22, 2025 | High confidence |
| US 8,507,499 | Substituted Indole/Indazole-Pyrimidinyl Compounds now held by Aclaris Therapeutics, Inc. Lapsed on the fee record Ended Aug 13, 2025 · High confidence | Lapsed on the fee record | Ended Aug 13, 2025 | High confidence |
| US 9,695,200 | Heterocyclic Itk Inhibitors for Treating Inflammation and Cancer now held by Aclaris Therapeutics, Inc. Lapsed on the fee record Ended Jul 4, 2025 · High confidence | Lapsed on the fee record | Ended Jul 4, 2025 | High confidence |
| US 9,505,765 | 4-Alkoxy/ARALKOXY-5-Substituted-PYRROLOPYRIMIDINE Compounds as TAK1 Inhibitors in Disease Treatment now held by Aclaris Therapeutics, Inc. Lapsed on the fee record Ended Nov 29, 2024 · High confidence | Lapsed on the fee record | Ended Nov 29, 2024 | High confidence |
| US 9,499,551 | SUBSTITUTED PYRROLO[2,3-b]PYRIDINES FOR TREATING CANCER OR INFLAMMATORY DISEASES now held by Aclaris Therapeutics, Inc. Lapsed on the fee record Ended Nov 22, 2024 · High confidence | Lapsed on the fee record | Ended Nov 22, 2024 | High confidence |
| US 9,365,546 | Substituted Pyridinone-Pyridinyl Compounds now held by Aclaris Therapeutics, Inc. Lapsed on the fee record Ended Jun 14, 2024 · High confidence | Lapsed on the fee record | Ended Jun 14, 2024 | High confidence |